Akiram Therapeutics to Showcase Key Data on AKIR001 at Targeted Radiopharmaceuticals Summit Europe 2024
Reading Time: 3 minutes Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, will present breakthrough IND-enabling preclinical data on its drug candidate 177Lu-AKIR001 and the design of its first-in-human clinical trial at the Targeted Radiopharmaceuticals Summit Europe 2024 in Amsterdam, December 3-5. The data
PUMA Signs Blockbuster Long-Term Partnership With the Portuguese Football Federation
Reading Time: 3 minutes Herzogenaurach, Germany: Sports company PUMA has signed a long-term agreement with the Portuguese Football Federation (FPF), one of the world’s most popular national teams. Starting in 2025, PUMA will equip all male, female and youth teams as well as the federation’s
Kesko Corporation: Disclosure in compliance with Chapter 9, Section 10 of the Finnish Securities Markets Act (26.11.2024)
Reading Time: 2 minutes Kesko Corporation has on 27 November 2024 received a notification pursuant to Chapter 9, Section 5 of the Finnish Securities Markets Act from BlackRock, Inc. According to the notification, on 26 November 2024, BlackRock, Inc.’s holding in Kesko Corporation exceeded the
Leqembi[®] launched in South Korea
Reading Time: 4 minutes Stockholm, Sweden, November 28, 2024 – BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced today that Leqembi® (generic name: lecanemab) has been launched in South Korea. Leqembi received approval in South Korea in May 2024 for treatment in adult
The Psychology of Online Lottery Bonuses: Insights from LottoRanker
Reading Time: 2 minutes Stockholm, Sweden – November 2024 — LottoRanker, a trusted authority in the world of online lottery, announces its latest exploration into the psychology behind online lottery bonuses and why they resonate with players. As the digital landscape of lottery gaming continues to
#24-407 Listing of Derivatives at NGM
Reading Time: < 1 minute Information about various derivatives that will be listed at NGM. For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market
#24-408 Delisting of Derivatives from NGM
Reading Time: < 1 minute Information about certain derivatives that will be delisted from NGM. For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market
Inside information: Bioretec Ltd successfully completes private placement raising EUR 6 million
Reading Time: 7 minutes Bioretec Ltd Inside information 27 November 2024 at 10.15 p.m. EET THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES OR IN
Nordea Bank Abp: Repurchase of own shares on 27.11.2024
Reading Time: < 1 minute Nordea Bank AbpStock exchange release – Changes in company’s own shares27.11.2024 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 27.11.2024 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading venue (MIC Code) Number of shares Weighted average
Panoro Energy ASA – Successful Placement of USD 150 Million Senior Secured Bond
Reading Time: 2 minutes Oslo, 27 November 2024 – Panoro Energy ASA (“Panoro” or the “Company”) is pleased to announce that it has successfully completed a 5-year senior secured bond issue of USD 150 million with a coupon rate of 10.25 per cent. The bonds